Systematic biopsies: Do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?

Radiology

Volumn 198, Issue 2, 1996, Pages 439-442

  Lee, W Robert ^a   Hanlon, Alexandra L ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Prostate, biopsy; Prostate, neoplasms; Prostate, therapeutic radiology

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0030027884     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.2.8596846     Document Type: Article

References (16)

1. McNeal JE. Cancer volume and site of origin of adenocarcinoma of the prostate: relationship to local and distant spread. Hum Pathol 1992; 23:258-266.
2. Stamey TA, Freiha TS, McNeal JE, et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71.933-938.
3. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate J Urol 1989; 142:71-75.
4. Hammerer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 1994, 151:99-102
5. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after prostatectomy. Urology 1994; 44:371-376
6. Peller PA, Young DC, Marmaduke DP, Marsh LW, Badalament RA. Sextant prostate biopsies, a histopathologic correlation with radical prostatectomy specimens. Cancer 1995; 75:530-538.
7. Stamey TA. Making the most out of systematic sextant biopsies. Urology 1995; 45: 2-12.
8. Zietman AL, Coen JJ, Shipley WU, Willett CG, Efird JT. Radical radiation therapy in the management of prostatic adenocarcinoma the initial prostate specific antigen value as a predictor of treatment outcome. J Urol 1994; 151:640-645.
9. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 1993; 20:713-725.
10. Lee WR, Hanks GE, Schultheiss TE, Corn BW, Hunt MA. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen-driven outcome analysis. J Clin Oncol 1995; 13:464-469.
11. American Joint Committee for the Staging of Cancer. Manual for staging of cancer. 4th ed. Philadelphia, Pa: Lippincott, 1992.
12. Soffen EM, Hanks GE, Hunt MA, Epstein BE. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. Int J Radiat Oncol Biol Phys 1992; 24:485-488.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:447-457.
14. Lawless JE. Statistical models and methods for lifetime data. New York, NY: Wiley, 1982.
15. Terris MK, McNeal JE, Stamey TA. Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies. J Urol 1992; 148:829-832.
16. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994; 152:1826-1830.